Low-Density Lipoprotein Cholesterol is Inversely Associated with All-Cause Mortality of Patients in the Coronary Care

Yingbei Weng1, Ripeng Yin1, Lala Qian1

  • 1Department of Cardiology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, 325000, Zhejiang, People's Republic of China.

Insights

High low-density lipoprotein cholesterol (LDL-C) levels are linked to decreased mortality in coronary care unit (CCU) patients. This finding suggests LDL-C may have prognostic value for CCU patient outcomes.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Epidemiology

Background:

  • Coronary care unit (CCU) patients face significant mortality risks.
  • The prognostic role of low-density lipoprotein cholesterol (LDL-C) in CCU patients remains incompletely understood.
  • Understanding factors influencing CCU patient outcomes is crucial for improving care.

Purpose of the Study:

  • To investigate the association between LDL-C levels and all-cause mortality in CCU patients.
  • To assess LDL-C's predictive value for CCU patient prognosis.
  • To adjust for potential confounding factors in the LDL-C mortality relationship.

Main Methods:

  • Retrospective analysis of 1476 CCU patients from the MIMIC-III database.
  • Primary endpoint: 30-day all-cause mortality; secondary endpoints: 90-day and one-year mortality, and infections.
  • Statistical analyses included Cox proportional hazard regression and propensity score-matched (PSM) analysis.

Main Results:

  • Higher LDL-C levels (≥ 55 mg/dl) were associated with significantly reduced 30-day, 90-day, and one-year all-cause mortality.
  • Hazard ratios for mortality decreased with higher LDL-C levels, even after adjusting for confounders.
  • Increased LDL-C levels correlated with a lower risk of infection.

Conclusions:

  • Elevated LDL-C levels are associated with a reduced risk of mortality in CCU patients.
  • The observed association between high LDL-C and lower mortality is robust, confirmed by PSM analysis.
  • Further validation in prospective trials is warranted.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
390
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
338
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
476
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
947
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
736